ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 159 filers reported holding ANIKA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $572,000 | -24.3% | 3,009 | -86.6% | 0.14% | -38.8% |
| Q4 2018 | $756,000 | -5.0% | 22,487 | +19.2% | 0.23% | +12.9% |
| Q3 2018 | $796,000 | +35.6% | 18,866 | +2.9% | 0.20% | +31.4% |
| Q2 2018 | $587,000 | -30.2% | 18,332 | +8.4% | 0.15% | -32.6% |
| Q1 2018 | $841,000 | -5.0% | 16,905 | +3.0% | 0.23% | -5.8% |
| Q4 2017 | $885,000 | -6.5% | 16,410 | +0.5% | 0.24% | -9.4% |
| Q3 2017 | $947,000 | +17.9% | 16,321 | +0.3% | 0.27% | +13.2% |
| Q2 2017 | $803,000 | +13.3% | 16,266 | -0.4% | 0.24% | +13.0% |
| Q1 2017 | $709,000 | -9.5% | 16,328 | +2.1% | 0.21% | -11.9% |
| Q4 2016 | $783,000 | +3.3% | 15,991 | -1.8% | 0.24% | -1.7% |
| Q3 2016 | $758,000 | -13.3% | 16,276 | -0.1% | 0.24% | -16.7% |
| Q2 2016 | $874,000 | +16.7% | 16,288 | -2.7% | 0.29% | +15.2% |
| Q1 2016 | $749,000 | +16.8% | 16,741 | -0.3% | 0.25% | +11.6% |
| Q4 2015 | $641,000 | – | 16,792 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |